"CenExel ACT, formerly Anaheim Clinical Trials (ACT), is a medical research center administrating Phase 1 – 4 clinical trials. For over two decades, CenExel ACT has been dedicated to assisting pharmaceutical companies find new cures to help patients better manage their healthcare. People volunteer to participate in medical research studies for a variety of reasons. Some hope to find a new treatment or cure for their disease. Others are looking for access to new drugs or free medical care. Many want the satisfaction of knowing that they may be helping someone with a chronic condition. We are dedicated to providing cutting edge therapy that can assist in managing patients’ chronic medical conditions today and for a lifetime."

During the past decade, Anaheim Clinical Trials, LLC conducted 176 clinical trials. In the 10-year time frame, 176 clinical trials started and 93 clinical trials were completed, i.e. on average, 52.8% percent of trials that started reached the finish line to date. In the past 5 years, 96 clinical trials started and 67 clinical trials were completed. i.e. 69.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Anaheim Clinical Trials, LLC" #1 sponsor was "Pfizer" with 42 trials, followed by "Eli Lilly and Company" with 14 trials sponsored, "Bristol-Myers Squibb" with 9 trials sponsored, "Celgene" with 7 trials sponsored and "Heron Therapeutics" with 7 trials sponsored. Other sponsors include 128 different institutions and companies that sponsored additional 86 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Anaheim Clinical Trials, LLC" #1 collaborator was "Pfizer" with 4 trials as a collaborator, "Department of Health and Human Services" with 3 trials as a collaborator, "Premier Research Group plc" with 3 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Anaheim Clinical Trials, LLC" are "Healthy Volunteers" (11 trials), "Obesity" (9 trials), "Pain, Postoperative" (8 trials), "Healthy" (7 trials) and "Acute Pain" (6 trials). Many other conditions were trialed in "Anaheim Clinical Trials, LLC" in a lesser frequency.

Most popular intervention types in "Anaheim Clinical Trials, LLC" are "Drug" (160 trials), "Biological" (50 trials), "Other" (31 trials), "Device" (7 trials) and "Combination Product" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (89 trials), "HB/APAP" (5 trials), "HTX-011" (5 trials), "20vPnC" (4 trials) and "Acetaminophen" (4 trials). Other intervention names were less common.

The vast majority of trials in "Anaheim Clinical Trials, LLC" are 206 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Anaheim Clinical Trials, LLC". undefined are not yet recruiting, 18 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 172 completed trials in Anaheim Clinical Trials, LLC, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Anaheim Clinical Trials, LLC, 67 "Phase 1" clinical trials were conducted, 67 "Phase 2" clinical trials and 77 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 3 trials that are defined as “Not Applicable".